The incidence of MDM2 gene amplification in human cancers is ~7% with soft tissue tumors, esophageal carcinomas and osteosarcoma typically having an increased frequency of MDM2 gene amplification [7,8]. The gene discussed is MDM2; the disease is soft tissue neoplasm.